GLASSBRIDGE ENT Revenue, Profits - GLAE Quarterly Income Statement

Add to My Stocks
$1 $0.23 (29.87%) GLAE stock closing price Jul 13, 2018 (Closing)

Financial statements provide us with a way to gain insights and undertake the fundamental analysis of a company. Checking GLASSBRIDGE ENT stock price alone is not sufficient. In the income statement, an investor can check for important parameters like the topline or sales, the bottomline or profits, the basic EPS, dividends etc. The income statement is always for an accounting period, typically for a year or quarter, and affects the stock. In this case, the GLAE stock is bound to reflect the impact of the QOQ growth of 6.82%. Along with GLASSBRIDGE ENT assets and GLASSBRIDGE ENT free cash flow, GLASSBRIDGE ENT profits as shown in profit and loss statement give key insights about the business. The net profit for 2018 Q1 is $-1.7M and the 2018 Q1 revenue is $9.4M.

View and download details of revenue and profits for GLASSBRIDGE ENT for latest & last 40 quarters.
show more
Quarterly
Annual
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q4
GLASSBRIDGE ENT Revenues or Net Sales
9.4M8.8M9.3M8.8M9.6M11.3M11.5M10.6M10.7M94M
Cost Of Goods Sold (COGS)4.5M4.6M5.3M4.7M5.2M6.2M6.3M5.9M6.3M69.1M
GLASSBRIDGE ENT Gross Profit
4.9M4.2M4M4.1M4.4M5.1M5.2M4.7M4.4M24.92M
Research & Development Expense1.2M1.6M1.8M2.2M2.5M2.4M2.9M3.2M3.4M4.8M
Selling General & Admin Expense5.3M9.3M8.5M7M9.3M7.8M10M7.3M17.4M19.8M
Income Before Depreciation Depletion Amortization-1.6M-6.7M-6.3M-5.1M-7.4M-5.1M-7.7M-5.8M-16.4M-
Depreciation Depletion Amortization-3.8M--------
Non Operating Income--1.1M-0.7M--4.1M--0.9M--0.1M
Interest Expense---------1.5M
GLASSBRIDGE ENT Pretax Income
-1.2M-10.3M-5.2M-5.8M-7.4M-9.2M-7.5M-6.7M-16.3M-1.3M
Provision for Income Taxes--2.3M-3.5M--0.1M2.4M-0.2M-0.5M-1.6M8.6M
MinorityInterest--4.7M-2M-2M-1.5M-----
Investment Gains Losses----------
Other Income----------
Income Before Extraordinaries & Disc Operations-1.3M-3.3M--3.9M-5.8M-11.6M-7.3M-6.2M-14.7M-9.9M
Extraordinary Items & Discontinued Operations-0.4M-0.2M7.7M-1.2M-2M-9.8M---76.4M-
GLASSBRIDGE ENT Profit/ Loss (Net Income)
-1.7M-3.5M8M-5.1M-7.8M-21.4M-7.1M-5.6M-91.1M-9.9M
Average Shares used to compute Diluted EPS5.1M5M5M5M4.1M3.6M3.71M3.72M3.71M3.7M
Average Shares used to compute Basic EPS5.1M5M5M5M4.1M3.6M3.71M3.72M3.71M3.7M
Income Before Nonrecurring Items-1.3M1.45M--4.5M-5.3M-11.28M-6M-7.2M-7.9M-4.9M
Income from Nonrecurring Items--4.75M---0.5M-0.33M-1.3M1M-6.8M-5M
GLASSBRIDGE ENT Earnings Per Share Basic Net
-0.33-0.701.60-1.02-1.90-6.03-1.90-1.50-24.60-2.70
GLASSBRIDGE ENT Earnings Per Share Diluted Net
-0.33-0.701.60-1.02-1.90-6.03-1.90-1.50-24.60-2.70
EPS Diluted Before Nonrecurring Items-0.250.290.06-0.90-1.29-3.18-1.60-2.00-2.10-1.30
Preferred Dividends Acc Pd----------
Dividends Common0.000.00--------
Dividend Per Share Common0.000.000.000.000.000.000.000.000.000.00
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Click here to view our NetApp financial analysis

GLASSBRIDGE ENT stock analysis involves checking at least a few of the important things like:

  • Revenue: This is the inflow that is generated from the sale of goods or services and is $9.4M for this quarter of 2018 Q1. Our GLASSBRIDGE ENT revenue chart gives a clear visual representation of how the topline or sales growth has been. Investors often invest only in those companies where the revenue is growing at a steady rate.
  • Bottom line: The word bottom line comes because it is usually the last line of the income statement and refers to the actual profits after deducting all expenses from the revenues. GLAE stock had a healthy bottom line growth.

The income statement is also called statement of revenue and expense. The GLAE financials along with GLASSBRIDGE ENT historical stock prices provide a lot of details about the firm.

GLASSBRIDGE ENT Income Statement - Key Financial Ratios

PS Ratio (price sales ratio)
0.11
Dividend Yield
0%